Structure

Physi-Chem Properties

Molecular Weight:  648.18
Volume:  631.2
LogP:  3.552
LogD:  2.531
LogS:  -4.021
# Rotatable Bonds:  13
TPSA:  195.35
# H-Bond Aceptor:  13
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.108
Synthetic Accessibility Score:  4.394
Fsp3:  0.294
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.819
MDCK Permeability:  3.834786548395641e-05
Pgp-inhibitor:  0.011
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.779
20% Bioavailability (F20%):  0.984
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.232
Plasma Protein Binding (PPB):  100.80176544189453%
Volume Distribution (VD):  0.855
Pgp-substrate:  2.498060941696167%

ADMET: Metabolism

CYP1A2-inhibitor:  0.085
CYP1A2-substrate:  0.061
CYP2C19-inhibitor:  0.714
CYP2C19-substrate:  0.067
CYP2C9-inhibitor:  0.834
CYP2C9-substrate:  0.585
CYP2D6-inhibitor:  0.957
CYP2D6-substrate:  0.093
CYP3A4-inhibitor:  0.819
CYP3A4-substrate:  0.25

ADMET: Excretion

Clearance (CL):  7.352
Half-life (T1/2):  0.913

ADMET: Toxicity

hERG Blockers:  0.072
Human Hepatotoxicity (H-HT):  0.053
Drug-inuced Liver Injury (DILI):  0.97
AMES Toxicity:  0.283
Rat Oral Acute Toxicity:  0.016
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.067
Carcinogencity:  0.339
Eye Corrosion:  0.003
Eye Irritation:  0.778
Respiratory Toxicity:  0.004

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475183

Natural Product ID:  NPC475183
Common Name*:   Itoside B
IUPAC Name:   [(2R,3S,4S,5R,6S)-5-benzoyloxy-3,4-dihydroxy-6-[4-hydroxy-2-[(1-hydroxy-6-oxocyclohex-2-ene-1-carbonyl)oxymethyl]phenoxy]oxan-2-yl]methyl benzoate
Synonyms:  
Standard InCHIKey:  QGZFGXHSODHGAW-PBWCLQEQSA-N
Standard InCHI:  InChI=1S/C34H32O13/c35-23-14-15-24(22(17-23)18-44-33(41)34(42)16-8-7-13-26(34)36)45-32-29(47-31(40)21-11-5-2-6-12-21)28(38)27(37)25(46-32)19-43-30(39)20-9-3-1-4-10-20/h1-6,8-12,14-17,25,27-29,32,35,37-38,42H,7,13,18-19H2/t25-,27-,28+,29-,32-,34?/m1/s1
SMILES:  C1CC(=O)C(C=C1)(C(=O)OCC2=C(C=CC(=C2)O)OC3C(C(C(C(O3)COC(=O)C4=CC=CC=C4)O)O)OC(=O)C5=CC=CC=C5)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL500459
PubChem CID:   44577044
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9317 Itoa orientalis Species Salicaceae Eukaryota bark, twigs, and leaves n.a. n.a. PMID[18412396]
NPO9317 Itoa orientalis Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens Inhibition = 61.0 % PMID[450888]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475183 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9872 High Similarity NPC475174
0.9808 High Similarity NPC280923
0.9675 High Similarity NPC474441
0.9675 High Similarity NPC476026
0.9675 High Similarity NPC474401
0.9675 High Similarity NPC474398
0.9563 High Similarity NPC280385
0.9487 High Similarity NPC231475
0.9487 High Similarity NPC57072
0.9355 High Similarity NPC299761
0.9355 High Similarity NPC279281
0.9355 High Similarity NPC92153
0.9355 High Similarity NPC230439
0.9325 High Similarity NPC470438
0.9286 High Similarity NPC93619
0.9286 High Similarity NPC131874
0.9245 High Similarity NPC71780
0.9245 High Similarity NPC132737
0.9156 High Similarity NPC22137
0.9091 High Similarity NPC140722
0.9091 High Similarity NPC4958
0.9091 High Similarity NPC92054
0.9026 High Similarity NPC474422
0.8924 High Similarity NPC215811
0.8868 High Similarity NPC260604
0.8868 High Similarity NPC299435
0.8846 High Similarity NPC83975
0.8805 High Similarity NPC183536
0.8805 High Similarity NPC34965
0.8797 High Similarity NPC475890
0.878 High Similarity NPC80068
0.8774 High Similarity NPC138915
0.8743 High Similarity NPC188815
0.8743 High Similarity NPC96605
0.8743 High Similarity NPC218161
0.8743 High Similarity NPC164704
0.8743 High Similarity NPC469344
0.8743 High Similarity NPC280642
0.8743 High Similarity NPC470712
0.8727 High Similarity NPC205824
0.8727 High Similarity NPC139060
0.8727 High Similarity NPC19240
0.8727 High Similarity NPC85751
0.8727 High Similarity NPC129264
0.8721 High Similarity NPC470416
0.8706 High Similarity NPC477895
0.8701 High Similarity NPC65833
0.8701 High Similarity NPC245219
0.8701 High Similarity NPC31081
0.8698 High Similarity NPC214621
0.8698 High Similarity NPC34267
0.8698 High Similarity NPC81042
0.8698 High Similarity NPC223426
0.869 High Similarity NPC101399
0.869 High Similarity NPC221288
0.869 High Similarity NPC257011
0.869 High Similarity NPC217822
0.869 High Similarity NPC470715
0.869 High Similarity NPC11847
0.869 High Similarity NPC474522
0.869 High Similarity NPC470716
0.869 High Similarity NPC470714
0.869 High Similarity NPC137871
0.869 High Similarity NPC288152
0.869 High Similarity NPC9002
0.8675 High Similarity NPC473278
0.8675 High Similarity NPC260504
0.8675 High Similarity NPC89809
0.8663 High Similarity NPC162394
0.8663 High Similarity NPC470718
0.8663 High Similarity NPC156785
0.8663 High Similarity NPC241781
0.8663 High Similarity NPC36138
0.8659 High Similarity NPC472994
0.8659 High Similarity NPC210961
0.8659 High Similarity NPC270675
0.8659 High Similarity NPC195685
0.8659 High Similarity NPC477628
0.8659 High Similarity NPC477629
0.8647 High Similarity NPC472992
0.8647 High Similarity NPC472991
0.8647 High Similarity NPC61904
0.8647 High Similarity NPC144097
0.8634 High Similarity NPC185103
0.8631 High Similarity NPC76047
0.8631 High Similarity NPC210808
0.8631 High Similarity NPC199079
0.8629 High Similarity NPC314672
0.8623 High Similarity NPC128403
0.8616 High Similarity NPC471214
0.8613 High Similarity NPC275977
0.8613 High Similarity NPC249560
0.8613 High Similarity NPC25946
0.8613 High Similarity NPC470720
0.8613 High Similarity NPC223860
0.8613 High Similarity NPC470717
0.8613 High Similarity NPC460984
0.8613 High Similarity NPC470713
0.8613 High Similarity NPC21359
0.8608 High Similarity NPC302989
0.8606 High Similarity NPC472876
0.8605 High Similarity NPC469371
0.8596 High Similarity NPC139571
0.8596 High Similarity NPC476619
0.8596 High Similarity NPC476618
0.8596 High Similarity NPC476622
0.8596 High Similarity NPC217520
0.8596 High Similarity NPC476620
0.8596 High Similarity NPC476623
0.8596 High Similarity NPC113836
0.8596 High Similarity NPC37668
0.8596 High Similarity NPC472387
0.8596 High Similarity NPC35167
0.8596 High Similarity NPC476621
0.8596 High Similarity NPC253521
0.858 High Similarity NPC47140
0.858 High Similarity NPC67134
0.8571 High Similarity NPC472133
0.8563 High Similarity NPC104910
0.8563 High Similarity NPC295625
0.8563 High Similarity NPC33083
0.8563 High Similarity NPC474093
0.8563 High Similarity NPC473554
0.8563 High Similarity NPC70441
0.8563 High Similarity NPC470719
0.8555 High Similarity NPC97119
0.8555 High Similarity NPC35924
0.8555 High Similarity NPC199172
0.8555 High Similarity NPC135831
0.8555 High Similarity NPC297503
0.8554 High Similarity NPC121290
0.8554 High Similarity NPC127415
0.8547 High Similarity NPC471030
0.8545 High Similarity NPC470125
0.8545 High Similarity NPC217950
0.8538 High Similarity NPC92403
0.8538 High Similarity NPC170018
0.8538 High Similarity NPC76112
0.8538 High Similarity NPC231787
0.8538 High Similarity NPC66820
0.8529 High Similarity NPC172033
0.8529 High Similarity NPC472993
0.8529 High Similarity NPC88560
0.8529 High Similarity NPC175230
0.8521 High Similarity NPC92815
0.8521 High Similarity NPC277532
0.8521 High Similarity NPC138990
0.8521 High Similarity NPC204937
0.8521 High Similarity NPC175429
0.8521 High Similarity NPC472129
0.8521 High Similarity NPC149011
0.8521 High Similarity NPC209550
0.8521 High Similarity NPC43434
0.8519 High Similarity NPC160882
0.8514 High Similarity NPC475179
0.8514 High Similarity NPC72554
0.8514 High Similarity NPC30011
0.8514 High Similarity NPC97817
0.8506 High Similarity NPC470455
0.8506 High Similarity NPC470451
0.8503 High Similarity NPC178281
0.8503 High Similarity NPC99216
0.85 High Similarity NPC182350
0.8494 Intermediate Similarity NPC90905
0.8494 Intermediate Similarity NPC4013
0.8488 Intermediate Similarity NPC258044
0.8488 Intermediate Similarity NPC293626
0.8488 Intermediate Similarity NPC267680
0.8488 Intermediate Similarity NPC196127
0.8488 Intermediate Similarity NPC217387
0.8485 Intermediate Similarity NPC328093
0.848 Intermediate Similarity NPC264735
0.848 Intermediate Similarity NPC49344
0.848 Intermediate Similarity NPC101191
0.848 Intermediate Similarity NPC477848
0.848 Intermediate Similarity NPC237435
0.848 Intermediate Similarity NPC135277
0.848 Intermediate Similarity NPC115760
0.848 Intermediate Similarity NPC210094
0.848 Intermediate Similarity NPC470667
0.848 Intermediate Similarity NPC43211
0.8476 Intermediate Similarity NPC177742
0.8471 Intermediate Similarity NPC102851
0.8471 Intermediate Similarity NPC5786
0.8471 Intermediate Similarity NPC315619
0.8462 Intermediate Similarity NPC145319
0.8462 Intermediate Similarity NPC95421
0.8462 Intermediate Similarity NPC198125
0.8462 Intermediate Similarity NPC246274
0.8452 Intermediate Similarity NPC64425
0.8448 Intermediate Similarity NPC470447
0.8448 Intermediate Similarity NPC470445
0.8448 Intermediate Similarity NPC470449
0.8448 Intermediate Similarity NPC470446
0.8443 Intermediate Similarity NPC121703
0.8443 Intermediate Similarity NPC227297
0.8439 Intermediate Similarity NPC58538
0.8434 Intermediate Similarity NPC216496
0.8434 Intermediate Similarity NPC282169
0.8434 Intermediate Similarity NPC159579

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475183 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8538 High Similarity NPD8312 Approved
0.8538 High Similarity NPD8313 Approved
0.8514 High Similarity NPD7879 Clinical (unspecified phase)
0.848 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD5402 Approved
0.8372 Intermediate Similarity NPD7808 Phase 3
0.8364 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8353 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8314 Intermediate Similarity NPD7251 Discontinued
0.8256 Intermediate Similarity NPD6797 Phase 2
0.8246 Intermediate Similarity NPD7054 Approved
0.8198 Intermediate Similarity NPD7472 Approved
0.8198 Intermediate Similarity NPD7074 Phase 3
0.8148 Intermediate Similarity NPD5403 Approved
0.8103 Intermediate Similarity NPD6559 Discontinued
0.8081 Intermediate Similarity NPD3751 Discontinued
0.8072 Intermediate Similarity NPD8455 Phase 2
0.807 Intermediate Similarity NPD6166 Phase 2
0.807 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8046 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD7075 Discontinued
0.8025 Intermediate Similarity NPD5401 Approved
0.7977 Intermediate Similarity NPD3818 Discontinued
0.7976 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7957 Intermediate Similarity NPD7435 Discontinued
0.7889 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD3787 Discontinued
0.7819 Intermediate Similarity NPD7870 Phase 2
0.7819 Intermediate Similarity NPD7871 Phase 2
0.7801 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7801 Intermediate Similarity NPD7874 Approved
0.7796 Intermediate Similarity NPD6781 Approved
0.7796 Intermediate Similarity NPD6776 Approved
0.7796 Intermediate Similarity NPD6777 Approved
0.7796 Intermediate Similarity NPD6780 Approved
0.7796 Intermediate Similarity NPD6778 Approved
0.7796 Intermediate Similarity NPD6782 Approved
0.7796 Intermediate Similarity NPD6779 Approved
0.7784 Intermediate Similarity NPD4380 Phase 2
0.7778 Intermediate Similarity NPD8150 Discontinued
0.7771 Intermediate Similarity NPD1653 Approved
0.7766 Intermediate Similarity NPD7698 Approved
0.7766 Intermediate Similarity NPD7697 Approved
0.7766 Intermediate Similarity NPD7696 Phase 3
0.7706 Intermediate Similarity NPD3817 Phase 2
0.7697 Intermediate Similarity NPD7685 Pre-registration
0.7696 Intermediate Similarity NPD7701 Phase 2
0.7692 Intermediate Similarity NPD6801 Discontinued
0.7668 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7668 Intermediate Similarity NPD7783 Phase 2
0.7647 Intermediate Similarity NPD7819 Suspended
0.7636 Intermediate Similarity NPD6799 Approved
0.7633 Intermediate Similarity NPD7411 Suspended
0.7627 Intermediate Similarity NPD5844 Phase 1
0.7624 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6823 Phase 2
0.7602 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD7699 Phase 2
0.7594 Intermediate Similarity NPD7700 Phase 2
0.7588 Intermediate Similarity NPD1934 Approved
0.7577 Intermediate Similarity NPD7801 Approved
0.7558 Intermediate Similarity NPD7768 Phase 2
0.7557 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD2801 Approved
0.7544 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD1551 Phase 2
0.7531 Intermediate Similarity NPD2935 Discontinued
0.7527 Intermediate Similarity NPD6534 Approved
0.7527 Intermediate Similarity NPD6535 Approved
0.7515 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6190 Approved
0.75 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1933 Approved
0.7486 Intermediate Similarity NPD8434 Phase 2
0.7485 Intermediate Similarity NPD7266 Discontinued
0.7485 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD6233 Phase 2
0.7457 Intermediate Similarity NPD3882 Suspended
0.7455 Intermediate Similarity NPD3750 Approved
0.7455 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD8320 Phase 1
0.7448 Intermediate Similarity NPD8319 Approved
0.744 Intermediate Similarity NPD1512 Approved
0.7439 Intermediate Similarity NPD1549 Phase 2
0.7436 Intermediate Similarity NPD1203 Approved
0.7405 Intermediate Similarity NPD6832 Phase 2
0.7403 Intermediate Similarity NPD1091 Approved
0.7394 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD6959 Discontinued
0.7385 Intermediate Similarity NPD8151 Discontinued
0.7381 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7228 Approved
0.7368 Intermediate Similarity NPD6599 Discontinued
0.7349 Intermediate Similarity NPD4628 Phase 3
0.7321 Intermediate Similarity NPD1511 Approved
0.7314 Intermediate Similarity NPD3749 Approved
0.7312 Intermediate Similarity NPD6798 Discontinued
0.731 Intermediate Similarity NPD7458 Discontinued
0.731 Intermediate Similarity NPD3226 Approved
0.7294 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD447 Suspended
0.7284 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD6844 Discontinued
0.7263 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD5494 Approved
0.7222 Intermediate Similarity NPD7473 Discontinued
0.7219 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD2313 Discontinued
0.7196 Intermediate Similarity NPD6213 Phase 3
0.7196 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD6212 Phase 3
0.7191 Intermediate Similarity NPD7199 Phase 2
0.7169 Intermediate Similarity NPD2346 Discontinued
0.7167 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1510 Phase 2
0.7152 Intermediate Similarity NPD7033 Discontinued
0.7152 Intermediate Similarity NPD3748 Approved
0.7151 Intermediate Similarity NPD6232 Discontinued
0.7143 Intermediate Similarity NPD1465 Phase 2
0.7134 Intermediate Similarity NPD9717 Approved
0.7108 Intermediate Similarity NPD2796 Approved
0.7107 Intermediate Similarity NPD7584 Approved
0.7091 Intermediate Similarity NPD7097 Phase 1
0.7086 Intermediate Similarity NPD37 Approved
0.7079 Intermediate Similarity NPD6234 Discontinued
0.7073 Intermediate Similarity NPD6355 Discontinued
0.707 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD4965 Approved
0.7062 Intermediate Similarity NPD4966 Approved
0.7062 Intermediate Similarity NPD4967 Phase 2
0.7048 Intermediate Similarity NPD4308 Phase 3
0.7044 Intermediate Similarity NPD3225 Approved
0.7027 Intermediate Similarity NPD7240 Approved
0.6995 Remote Similarity NPD7799 Discontinued
0.6994 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6994 Remote Similarity NPD411 Approved
0.6985 Remote Similarity NPD7585 Approved
0.697 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6957 Remote Similarity NPD2798 Approved
0.6946 Remote Similarity NPD2799 Discontinued
0.6935 Remote Similarity NPD7583 Approved
0.6933 Remote Similarity NPD7095 Approved
0.6923 Remote Similarity NPD970 Clinical (unspecified phase)
0.6909 Remote Similarity NPD1240 Approved
0.6909 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6909 Remote Similarity NPD1613 Approved
0.6906 Remote Similarity NPD8127 Discontinued
0.6905 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6905 Remote Similarity NPD8059 Phase 3
0.6894 Remote Similarity NPD2797 Approved
0.689 Remote Similarity NPD3268 Approved
0.689 Remote Similarity NPD3764 Approved
0.6865 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6863 Remote Similarity NPD7930 Approved
0.686 Remote Similarity NPD7440 Discontinued
0.6852 Remote Similarity NPD1019 Discontinued
0.6839 Remote Similarity NPD6273 Approved
0.6837 Remote Similarity NPD8285 Discontinued
0.6831 Remote Similarity NPD3926 Phase 2
0.6826 Remote Similarity NPD1607 Approved
0.681 Remote Similarity NPD2861 Phase 2
0.6807 Remote Similarity NPD4060 Phase 1
0.6807 Remote Similarity NPD4307 Phase 2
0.6805 Remote Similarity NPD6099 Approved
0.6805 Remote Similarity NPD5404 Approved
0.6805 Remote Similarity NPD6100 Approved
0.6805 Remote Similarity NPD5406 Approved
0.6805 Remote Similarity NPD5408 Approved
0.6805 Remote Similarity NPD5405 Approved
0.6796 Remote Similarity NPD919 Approved
0.6795 Remote Similarity NPD9493 Approved
0.6792 Remote Similarity NPD3496 Discontinued
0.6786 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6784 Remote Similarity NPD6674 Discontinued
0.6784 Remote Similarity NPD7680 Approved
0.6768 Remote Similarity NPD4908 Phase 1
0.6766 Remote Similarity NPD230 Phase 1
0.6765 Remote Similarity NPD5762 Approved
0.6765 Remote Similarity NPD5763 Approved
0.6765 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6765 Remote Similarity NPD2344 Approved
0.6755 Remote Similarity NPD7038 Approved
0.6755 Remote Similarity NPD7039 Approved
0.6747 Remote Similarity NPD4062 Phase 3
0.6744 Remote Similarity NPD8166 Discontinued
0.6744 Remote Similarity NPD7003 Approved
0.6743 Remote Similarity NPD5049 Phase 3
0.674 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6726 Remote Similarity NPD6653 Approved
0.6721 Remote Similarity NPD1247 Approved
0.672 Remote Similarity NPD7549 Discontinued
0.672 Remote Similarity NPD7177 Discontinued
0.6715 Remote Similarity NPD8404 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data